ATH 20.0% 0.4¢ alterity therapeutics limited

new alzheimer's detection test

  1. 12,893 Posts.
    CGS has a very interesting announcement out this morning about a new test for the early detection of Alzheimer's disease.

    http://www.asx.com.au/asxpdf/20121016/pdf/429dklx9rm8pz6.pdf

    They have found that people with elevated levels of beta amyloid can be used as a marker for very early stages of the disease.

    What they have found is that people who do not display any symptoms of Alzheimers but have high beta amyloid in the brain, over time, showed a subtle but progressive decline in their memory.

    This sounds like further evidence supporting PBT's research with their candidate PBT2, which works by preventing the accumulation of the beta amyloid protein in the brain.

    This story continues to become more compelling over time.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(20.0%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $640 160.0K

Buyers (Bids)

No. Vol. Price($)
57 68540898 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 34431662 24
View Market Depth
Last trade - 10.21am 08/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.